Compugen Ltd. CGEN

NAS: CGEN | ISIN: IL0010852080 17/09/2025

1,360 USD (-1,45%)

(-1,45%) 17/09/2025

Grafiek Compugen Ltd.

Grafiek Compugen Ltd.

1 dag1d -1,45%
1 week1w -2,86%
1 maand1m -12,26%
3 maanden3m -17,58%
6 maanden6m -13,38%
1 jaar1j -28,42%
5 jaar5j -92,79%

Compugen Ltd. in het nieuws

Toon enkel gratis nieuws

8 september 2025 · Compugen to Present Research at the Single Cell Genomics 2025 Conference · Persbericht

28 augustus 2025 · Compugen to Present at the H.C. Wainwright 27th Annual Global Investment Conference · Persbericht

6 augustus 2025 · Compugen Reports Second Quarter 2025 Results · Persbericht

28 juli 2025 · Compugen to Present a Pooled Analysis of COM701 Phase 1 trials in Platinum Resistant Ovarian Cancer at ESMO 2025 · Persbericht

23 juli 2025 · Compugen to Release Second Quarter 2025 Results on Wednesday, August 6, 2025 · Persbericht

21 juli 2025 · Compugen Announces First Patient Dosed in COM701 Global Platform Trial in Platinum Sensitive Ovarian Cancer · Persbericht

12 juni 2025 · Compugen to Present AI/ML Driven Predictive Computational Research at Upcoming International Scientific Conferences · Persbericht

19 mei 2025 · Compugen Reports First Quarter 2025 Results · Persbericht

13 mei 2025 · Compugen Announces Leadership Transitions Effective September 2025 · Persbericht

5 mei 2025 · Compugen to Release First Quarter 2025 Results on Monday, May 19, 2025 · Persbericht

Profiel Compugen Ltd.

Gezondheidstechnologie

Website: www.cgen.com

Hoofdzetel: Holon Israël

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe